US company Thermo Fischer has been given the go-ahead to buy Swedish company Phadia, the European Commission announced on 19 August.
The Commission said the merger would not impede competition because the companies are not close competitors and have competitors in the field of in vitro autoimmune disease diagnostics.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.